Medeia Therapeutics Overview

  • Founded
  • 2006
Founded
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Medeia Therapeutics General Information

Description

Developer of novel therapies for treatment of neurodegenerative diseases. The company is a biotechnology enterprise focusing on the discovery and early development of novel therapies for life-threatening, degenerative human diseases. Its R&D programs aim at developing small molecule therapies for life-threatening conditions of the elderly, focusing especially on diseases such as Alzheimer's, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS) and other degenerative diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Post Box 1188
  • 70211 Kuopio
  • Finland
+358 044 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medeia Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-May-2016 00.000 Completed Out of Business
5. Secondary Transaction - Private 23-Mar-2015 00.000 Completed Generating Revenue
4. Grant 20-Mar-2012 00000 00.000 Completed Generating Revenue
3. Grant 17-Feb-2010 00000 00.000 Completed Startup
2. Early Stage VC 27-Jan-2009 $3.01M $3.01M Completed Startup
1. Early Stage VC Completed Startup
To view Medeia Therapeutics’s complete valuation and funding history, request access »

Medeia Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of novel therapies for treatment of neurodegenerative diseases. The company is a biotechnology enterprise focu
Biotechnology
Kuopio, Finland
00.000
00000000 00 00.000

00000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000 000000000
Clarksville, MD
0 As of 0000
00.000
000000 0

0000000

a pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt molli
0000 000000000
Framingham, MA
00 As of 0000
000.00
0000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medeia Therapeutics Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 000000 0
0000000 Venture Capital-Backed Framingham, MA 00 000.00 0000000000 000.00
00000 000000000000 Formerly VC-backed Grand Rapids, MI 0 0000 000000&0 0000
000000 00000000000 Venture Capital-Backed South San Francisco, CA 00 00000 0000000000 0 00000
0000000 Formerly VC-backed Calabasas, CA 00 0000 000000&0 0000
You’re viewing 5 of 35 competitors. Get the full list »

Medeia Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Jari Koistinaho Ph.D Board Member & Scientific Founder
Jari Ratilainen Ph.D Head, Medicinal Chemistry
You’re viewing 2 of 4 executive team members. Get the full list »

Medeia Therapeutics Board Members (5)

Name Representing Role Since
Jari Koistinaho Ph.D Medeia Therapeutics Board Member & Scientific Founder 000 0000
Kalevi Reijonen MD Self Board Member 000 0000
You’re viewing 2 of 5 board members. Get the full list »